Showing results (1-10 of 94) with videos related to
Sort By:
Pageof 10
Biochimica Et Biophysica Acta|November 20, 2012
Chemokines in tissue fibrosisHacer Sahin, Hermann E WasmuthNature Reviews. Gastroenterology & Hepatology|October 27, 2010
Functional role of chemokines in liver disease modelsHacer Sahin, Christian Trautwein, Hermann E WasmuthExpert Review of Clinical Pharmacology|November 26, 2011
Therapeutic potential of chemokine receptor antagonists for liver diseaseHacer Sahin, Marie-Luise Berres, Hermann E WasmuthChannels (Austin, Tex.)|October 16, 2012
Strong activation of bile acid-sensitive ion channel (BASIC) by ursodeoxycholic acidDominik Wiemuth, Hacer Sahin, Cathérine M T Lefèvre, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 28, 2012
BASIC--a bile acid-sensitive ion channel highly expressed in bile ductsDominik Wiemuth, Hacer Sahin, Björn H Falkenburger, et al.Plos One|June 27, 2013
The chemokine CCL3 promotes experimental liver fibrosis in miceDaniel Heinrichs, Marie-Luise Berres, Andreas Nellen, et al.Plos One|May 11, 2012
Interference with oligomerization and glycosaminoglycan binding of the chemokine CCL5 improves experimental liver injuryAndreas Nellen, Daniel Heinrichs, Marie-Luise Berres, et al.Plos One|February 26, 2013
Overexpression of endoglin modulates TGF-β1-signalling pathways in a novel immortalized mouse hepatic stellate cell lineSteffen K Meurer, Muhammad Alsamman, Hacer Sahin, et al.Laboratory Investigation; a Journal of Technical Methods and Pathology|March 21, 2012
The chemokine receptor CXCR3 limits injury after acute toxic liver damageMirko Moreno Zaldivar, Marie-Luise Berres, Hacer Sahin, et al.Best Practice & Research. Clinical Gastroenterology|October 20, 2010
Liver fibrosis: from animal models to mapping of human risk variantsSusanne N Weber, Hermann E WasmuthPageof 10